Chearwae and Bright [46] reported that PPARγ agonists inhibited growth and expression of brain tumor stem cells by inhibition of EGF/bFGF signaling through Tyk2-Stat3 pathway and the expression of PPARγ. Here, PPARG is linked to brain neoplasm.